| 1 |
Trulson I, Stahl J, Margraf S, Scholz M, Hoecherl E, Wolf K, Durner J, Klawonn F, Holdenrieder S. Cell-Free DNA in Plasma and Serum Indicates Disease Severity and Prognosis in Blunt Trauma Patients. Diagnostics 2023;13:1150. [DOI: 10.3390/diagnostics13061150] [Reference Citation Analysis]
|
| 2 |
Műzes G, Bohusné Barta B, Szabó O, Horgas V, Sipos F. Cell-Free DNA in the Pathogenesis and Therapy of Non-Infectious Inflammations and Tumors. Biomedicines 2022;10. [PMID: 36359370 DOI: 10.3390/biomedicines10112853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Fathima N, Manorenj S, Vishwakarma SK, Khan AA. Role of cell-free DNA for predicting incidence and outcome of patients with ischemic stroke. World J Neurol 2022; 8(1): 1-9 [DOI: 10.5316/wjn.v8.i1.1] [Reference Citation Analysis]
|
| 4 |
Fathima N, Manorenj S, Vishwakarma SK, Khan AA. Cell-free mitochondrial DNA quantification in ischemic stroke patients for non-invasive and real-time monitoring of disease status. World J Transl Med 2022; 10(2): 14-28 [DOI: 10.5528/wjtm.v10.i2.14] [Reference Citation Analysis]
|
| 5 |
Sharma D, Spring KJ, Bhaskar SMM. Neutrophil-lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis. Acta Neurol Scand 2021;144:486-99. [PMID: 34190348 DOI: 10.1111/ane.13493] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 6 |
Orbán-Kálmándi R, Szegedi I, Sarkady F, Fekete I, Fekete K, Vasas N, Berényi E, Csiba L, Bagoly Z. A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis. Sci Rep 2021;11:12713. [PMID: 34135389 DOI: 10.1038/s41598-021-92041-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Paracchini L, D'Incalci M, Marchini S. Liquid Biopsy in the Clinical Management of High-Grade Serous Epithelial Ovarian Cancer-Current Use and Future Opportunities. Cancers (Basel) 2021;13:2386. [PMID: 34069200 DOI: 10.3390/cancers13102386] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Bunnapradist S, Datta N, Schaenman J, Ioannou N, Bloom MS, Malhotra M, Tabriziani H, Gauthier P, Ahmed E, Billings PR, Lum EL. Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection. Transplant Direct 2021;7:e691. [PMID: 33912658 DOI: 10.1097/TXD.0000000000001145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 9 |
Azar J, Salama M, Chidambaram SB, Al‐balushi B, Essa MM, Qoronfleh MW. Precision health in Alzheimer disease: Risk assessment‐based strategies. Precision Medical Sciences 2021;10:54-70. [DOI: 10.1002/prm2.12036] [Reference Citation Analysis]
|
| 10 |
Escorcia JV. Circulating cell-free DNA biomarkers. APIK J Int Med 2021;9:273. [DOI: 10.4103/ajim.ajim_85_21] [Reference Citation Analysis]
|
| 11 |
Crigna AT, Samec M, Koklesova L, Liskova A, Giordano FA, Kubatka P, Golubnitschaja O. Cell-free nucleic acid patterns in disease prediction and monitoring-hype or hope? EPMA J 2020;:1-25. [PMID: 33144898 DOI: 10.1007/s13167-020-00226-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
|
